As a part of CPIC, Dr. Uppugunduri is involved in the development of a clinical guidelines for personalized proton pump inhibitor dosing based on CYP2C19 gene (in development). He is also a member of the educational division of European Society of Pharmacogenomics and Personalized Therapy (ESPT). Dr. Uppugunduri is involved in knowledge dissemination via virtual platforms for e.g. he founded a forum on personalized medicine earlier in nature work, and currently available at www.personalizedmedicine.in to engage researchers with similar interests and to have a dialogue.
Dr. Uppugunduri is currently working at Onco-Hematology unit, Department of Paediatrics, Gynaecology and Obstetrics, University of Geneva. He is also affiliated to a foundation supporting the research in pediatric onco-hematology (www.cansearch.ch). Dr. Uppugunduri is a recognized Clinical Pharmacologist (NON MD title by Swiss Society of Clinical Pharmacology and Toxicology) and participates in the implementation of therapeutic drug monitoring. He works with multidisciplinary team at his unit and laboratory, has strong collaboration with the teams of Clinical Pharmacology and Toxicology Division (https://www.hug-ge.ch/pharmacologie-toxicologie-cliniques) at University Hospitals of Geneva (University of Geneva). Dr. Uppugunduri is working with the objective of developing, evaluating, interpreting new/existing pharmacogenetics markers with clinical utility. He is also participating in teaching /education of medical doctors/allied health professionals in training on topics in clinical pharmacology and pharmacogenetics.
PGRN Hub & the Featured Investigator